4-nitroquinoline-1-oxide has been researched along with ono 8711 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fujitsuka, H; Kobayashi, A; Makita, H; Maruyama, T; Miyamoto, S; Mutoh, M; Shibata, T; Suzuki, R; Tanaka, T; Toida, M; Wakabayashi, K; Yasui, Y; Yonemoto, K | 1 |
1 other study(ies) available for 4-nitroquinoline-1-oxide and ono 8711
Article | Year |
---|---|
A prostaglandin E2 receptor subtype EP1-selective antagonist, ONO-8711, suppresses 4-nitroquinoline 1-oxide-induced rat tongue carcinogenesis.
Topics: 4-Nitroquinoline-1-oxide; Animal Feed; Animals; Bridged Bicyclo Compounds; Caproates; Carcinogens; Carcinoma, Squamous Cell; Dinoprostone; Male; Precancerous Conditions; Rats; Rats, Inbred F344; Receptors, Prostaglandin E; Tongue; Tongue Neoplasms | 2007 |